EnbrelŪ

• Initial Approval for Severe Rheumatoid Arthritis in September 1998

  • Juvenile Chronic Arthritis Approved in May 1999
  • DMARD/ Early RA Approved in June 2000

• In Phase III Trials for Psoriatic Arthritis

  • sNDA Submission 2001

• In Phase II Trials for Psoriasis

• Commercial Product Available From Rhode Island Facility 2H2002

Early RA

Indication

JRA

Indication

Previous slide

Next slide

Back to first slide

View graphic version